• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911332270
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Congestive Heart Failure (1783); Reocclusion (1985)
Event Date 09/09/2015
Event Type  Injury  
Manufacturer Narrative
(b)(6).Device is combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(4).Same case as mdr id: 2134265-2016-01522 and 2134265-2016-01523.It was reported that worsening heart insufficiency occurred.The patient was enrolled in the (b)(4) study in (b)(6) 2011.They presented due to unstable angina and was referred for cardiac catheterization.The first target lesion was a de novo lesion located in the proximal right coronary artery (rca) with 80 % stenosis and was 12 mm long with a reference vessel diameter of 3.00 mm.This lesion was treated with direct placement of a 3.00 mm x 16 mm promus element stent.Following post dilatation, residual stenosis was 0%.The second target lesion was a de novo lesion located in the distal rca with 99 % stenosis and was 20 mm long with a reference vessel diameter of 2.5 mm.This lesion was treated with pre-dilatation and placement of a 2.75 mm x 32 mm and 2.50 mm x 32 mm promus element stents.Following post dilatation, residual stenosis was 5%.One day later, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2015, the patient was diagnosed with worsening heart insufficiency and atrial fibrillation and was hospitalized on the same day.Revascularization was done to treat the worsening heart insufficiency which failed.While electrocardioversion was done to treat atrial fibrillation.Five days later, the events were considered to be resolved without residual effects and the subject was discharged on the same day.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that in (b)(6) 2015, coronary angiography revealed complete occlusion of mid rca.The study stent was placed in distal rca while the stent thrombosis was identified in mid rca.One day later, percutaneous coronary intervention (pci) was performed to treat the complete occlusion of previously placed stent in mid rca extending to distal rca.However, the revascularization failed and the residual stenosis was 100%.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that there was a restenosis of the previously placed study stents in mid rca and distal rca.Since the revascularization was unsuccessful, medical treatment was optimized.The patient was already on heart failure and antihypertensive therapy which was intensified with the addition of a loop diuretic.Also, there was an increased risk of stroke after the onset of atrial fibrillation (treated by electrocardioversion) for which oral anticoagulation treatment with apixaban (2 x 5 mg/day) was started.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5511853
MDR Text Key40726404
Report Number2134265-2016-01524
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/02/2012
Device Model NumberH7493911332270
Device Catalogue Number39113-3227
Device Lot Number13990729
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/08/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/04/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-